Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant pseudomonas aeruginosa

CEFTABUSE study group

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1799-1801
Number of pages3
JournalClinical Infectious Diseases
Issue number7
Publication statusPublished - Oct 1 2020

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this